NULISA (A NOVEL PROTEOMIC LIQUID BIOPSY PLATFORM WITH ATTOMOLAR SENSITIVITY AND HIGH MULTIPLEXING) TESTING SERVICES TO IDENTIFY BIOMARKERS THAT PROVIDE INFORMATION ABOUT THE UNDERLYING MOLECULAR CHANGES ASSOCIATED WITH AD/ADRD.
$2,332,200
| Recipient | — |
|---|---|
| Award ID | 75N98026P00871 |
| Award amount | $2,332,200 |
| Award type | PURCHASE ORDER |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541380 |
| PSC | Q301 |
| Start date | Aug 1, 2026 |
| End date | Jul 31, 2027 |
| Place of performance | ROCKVILLE, MD |
View the official award record
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids